IFNG and neoplasm: Tumor-infiltrating CD8POS T cells retained the ability to secrete IFN-γ following MHC-I presentation of the tumor neoantigen, mImp3 by naive DCs,43 indicating the presence of a tumor-Ag-specific TCR.